In the pharmaceutical context, the term “biologics” generally refers to protein-based medicines that are made in living cells, such as insulin and human growth hormone.
Register now for your free, tailored, daily legal newsfeed service.
Questions? Please contact email@example.comRegister
Variations on a theme: five proposed abbreviated approval pathways for biogenerics
To view this article you need a PDF viewer such as Adobe Reader.
Popular articles from this firm
If you would like to learn how Lexology can drive your content marketing strategy forward, please email firstname.lastname@example.org.
Related topic hubs
The Taubman Company
"I enjoy your publication and read it religiously."